After the Woodford fallout, is it time to buy Hargreaves Lansdown and Patient Capital?

Two of the biggest casualties from Neil Woodford’s fall from grace are his investment trust - Woodford Patient Capital - and broker Hargreaves Lansdown. John Stepek looks at whether you should snap them up or leave them well alone.

190611-woodford

1129697289
(Image credit: © 2019 SOPA Images)

Quick reminder: Dominic and I will be talking to currency expert Alex Edwards of OFX live in a webinar at 1pm this afternoon. If you'd like to watch and ask us questions, sign up here it's free. (And if you sign up you'll be able to access the content later, even if you can't attend live).

Start your trial of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up
Latest Videos FromMoneyWeek
John Stepek
Former editor, MoneyWeek